Akso Health Group annual r&d spending
2016
2017
2018
2019
2020
2021
2022
Akso Health Group R&D Spending Growth & History (AHG)
Akso Health Group's r&d spending was $421,186 for fiscal 2022.
View full Akso Health Group company overviewAkso Health Group annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-03-31 | $421,186 | −$20,219 | −4.58% |
| 2021 | 2021-03-31 | $441,405 | $323,463 | +274.26% |
| 2020 | 2020-03-31 | $117,942 | −$1.0M | −89.76% |
| 2019 | 2019-03-31 | $1.2M | −$1.7M | −59.13% |
| 2018 | 2018-03-31 | $2.8M | $1.2M | +79.69% |
| 2017 | 2017-03-31 | $1.6M | $671,745 | +74.97% |
| 2016 | 2016-03-31 | $895,993 | — | — |
Akso Health Group r&d spending trends
Over the last five fiscal years, Akso Health Group's r&d spending decreased from $1.6M to $421,186, a change of −$1.1M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Akso Health Group source filings ↗